INOVIO PHARMACEUTICALS INC (INO) Forecast, Price Target & Analyst Ratings

NASDAQ:INO • US45773H4092

Current stock price

1.58 USD
+0.01 (+0.64%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INOVIO PHARMACEUTICALS INC (INO).

Forecast Snapshot

Consensus Price Target

Price Target
$8.36
+ 429.37% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.36
Revenue Estimate
336.663K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.36
Upside
+ 429.37%
From current price of $1.58 to mean target of $8.36, Based on 10 analyst forecasts
Low
$1.82
Median
$9.18
High
$13.65

Price Target Revisions

1 Month
-4.21%
3 Months
7.42%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for INO. The average price target is 8.36 USD. This implies a price increase of 429.37% is expected in the next year compared to the current price of 1.58.
The average price target has been revised upward by 7.42% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INO Current Analyst RatingINO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

INO Historical Analyst RatingsINO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
INO was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about INO.
In the previous month the buy percentage consensus was at a similar level.
INO was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-14Piper SandlerReiterate Overweight -> Overweight
2025-08-14HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-07-09Piper SandlerInitiate Overweight
2025-05-14OppenheimerMaintains Outperform -> Outperform
2025-05-14RBC CapitalReiterate Sector Perform -> Sector Perform
2025-03-19RBC CapitalMaintains Sector Perform -> Sector Perform
2025-03-19HC Wainwright & Co.Reiterate Neutral -> Neutral
2025-03-14Citizens Capital MarketsReiterate Market Outperform -> Market Outperform
2025-01-13HC Wainwright & Co.Maintains Neutral -> Neutral
2025-01-10JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-11-18OppenheimerMaintains Outperform -> Outperform
2024-11-18HC Wainwright & Co.Maintains Neutral -> Neutral
2024-11-15RBC CapitalMaintains Sector Perform -> Sector Perform
2024-10-04RBC CapitalMaintains Sector Perform -> Sector Perform
2024-08-12OppenheimerMaintains Outperform -> Outperform
2024-08-09RBC CapitalMaintains Sector Perform -> Sector Perform
2024-07-15HC Wainwright & Co.Reiterate Neutral -> Neutral
2024-05-14Stephens & Co.Initiate Overweight
2024-03-08OppenheimerMaintains Outperform -> Outperform
2024-03-07RBC CapitalReiterate Sector Perform -> Sector Perform
2024-01-25OppenheimerUpgrade Perform -> Outperform
2024-01-04JMP SecuritiesInitiate Market Outperform
2023-05-11RBC CapitalReiterate Sector Perform -> Sector Perform
2023-03-02RBC CapitalMaintains Sector Perform
2022-11-09Maxim GroupDowngrade Buy -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.36
Revenue Estimate
336.663K
Revenue Q2Q
417.94%
EPS Q2Q
11.32%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
2.70%
EPS (3 Months)
2.70%

Next Earnings Summary

INO is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.36 USD and the consensus revenue estimate is 336.66K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
INO revenue by date.INO revenue by date.
832K
-91.89%		217.8K
-73.82%		65.3K
-70.02%		16.014M
24,423.74%		69.085M
331.40%		176.6M
155.63%		250.44M
41.81%		286.28M
14.31%		294.41M
2.84%		290.42M
-1.36%		283.63M
-2.34%
EBITDA
YoY % growth
INO ebitda by date.INO ebitda by date.
-130.66M
50.40%		-110.647M
15.32%		-85.404M
22.81%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
INO ebit by date.INO ebit by date.
-133.427M
50.13%		-112.399M
15.76%		-86.822M
22.76%		-80.255M
7.56%		-47.365M
40.98%		50.703M
207.05%		66.95M
32.04%		93.631M
39.85%		81.196M
-13.28%		65.931M
-18.80%		75.794M
14.96%
Operating Margin
INO operating margin by date.INO operating margin by date.
-16,036.90%-51,606.47%-132,958.81%-501.15%-68.56%28.71%26.73%32.71%27.58%22.70%26.72%
EPS
YoY % growth
INO eps by date.INO eps by date.
-6.16
56.50%		-3.99
35.23%		-1.83
54.14%		-1.46
20.26%		-0.19
87.20%		0.35
286.49%		0.89
155.07%		1.19
34.09%		0.98
-17.80%		0.78
-20.62%		1.12
44.16%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.36
11.32%		-0.28
54.19%		-0.27
69.04%		-0.22
-470.33%
Revenue
Q2Q % growth		336.663K
417.94%		538.663K2.323M6.902M
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-21.564M
13.92%		-23.836M
-3.26%		-23.432M
-10.47%		-22.372M
-28.01%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INO Yearly Revenue VS EstimatesINO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50M 100M 150M 200M 250M
INO Yearly EPS VS EstimatesINO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
29.87%
EPS Next 5 Year
21.53%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1,134.23%
Revenue Next 5 Year
397.51%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INOVIO PHARMACEUTICALS INC / INO Forecast FAQ

What do analysts expect the price target to be for INOVIO PHARMACEUTICALS INC (INO)?

10 analysts have analysed INO and the average price target is 8.36 USD. This implies a price increase of 429.37% is expected in the next year compared to the current price of 1.58.

When does INOVIO PHARMACEUTICALS INC (INO) report earnings?

INOVIO PHARMACEUTICALS INC (INO) will report earnings on 2026-05-11.

Can you provide the consensus estimates for INOVIO PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of INOVIO PHARMACEUTICALS INC (INO) is -0.36 USD and the consensus revenue estimate is 336.66K USD.

What is the expected long term growth rate for INOVIO PHARMACEUTICALS INC (INO)?

The expected long term growth rate for INOVIO PHARMACEUTICALS INC (INO) is 1134.23%.